Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2503 of 6351
-
New drug aims to boost immune system against advanced cancers
Disease control OngoingThe objective of study IOA-244-101 is to determine whether IOA-244 is safe and tolerable in cancer patients (Part A). In addition, the study will assess whether IOA-244 can increase the anti-tumour immune response in patients both as monotherapy and in combination pemetrexed/cisp…
Phase 1 • Sponsor: iOnctura • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a simple blood injection revive aging ovaries?
Disease control OngoingConsenting women with evidence of poor ovarian reserve will be randomly assigned to treatment with either Platelet Rich Plasma (PRP) or Platelet Poor Plasma (PPP).
Sponsor: Center for Human Reproduction • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could a common diabetes drug help repair MS damage in kids?
Disease control Recruiting nowA randomized multiple baseline feasibility trial where participants will start taking metformin at one of 3 randomly determined points (3-months, 6-months or 9 months) during the 12-month trial. All subjects will be on a daily dose of metformin for a minimum of 3 months and a max…
Phase 1/2 • Sponsor: The Hospital for Sick Children • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New rapid test could slash antibiotic misuse in hospital pneumonia
Diagnosis CompletedHospital-Acquired Pneumonia (HAP) is the second most frequent hospital-acquired infection in the US and Europe and accounts for a large proportion of antibiotics prescribed in hospitals. Conventional methods to identify causative microorganisms (virus, bacteria) are time-consumin…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Aug 14, 2026 00:00 UTC
-
Experimental cell therapy takes on Hard-to-Treat blood cancers
Disease control CompletedThis is a Phase 1/2, study evaluating IOV-2001 (Adoptive Cell Therapy) composed of autologous PBL (Peripheral Blood Lymphocytes) in patients with CLL/SLL, which has relapsed or is relapsing during treatment with ibrutinib or acalabrutinib.
Phase 1 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Ulcerative colitis study aims to pinpoint the perfect treatment goal
Knowledge-focused OngoingDisease activity and response to therapy in ulcerative colitis (UC) can be assessed by a range of endpoints including symptoms, endoscopic mucosal activity, histological disease activity, and biomarkers. This study aims to determine the optimal treatment target, which is a resear…
Phase 4 • Sponsor: Alimentiv Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Elbow nerve surgery showdown: which procedure works best?
Symptom relief OngoingThis research is studying two surgical procedures in a large group of people to learn about how well these procedures work as a treatment for ulnar neuropathy at the elbow (UNE). Researchers want to see which surgery is more helpful for people with ulnar neuropathy. This research…
Sponsor: University of Michigan • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
New HIV pill combo could simplify treatment for thousands
Disease control CompletedThis study will evaluate the safety and efficacy of a switch to Doravirine/Islatravir (DOR/ISL) (MK-8591A) (a fixed dose combination of doravirine 100 mg and islatravir 0.75 mg) in participants living with human immunodeficiency virus-1 (HIV-1) virologically suppressed on a regim…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a cancer drug shrink NF2 tumors?
Disease control CompletedSubjects with Neurofibromatosis Type 2 (NF2) and progressive vestibular schwannoma (VS) will be treated with crizotinib administered orally. Crizotinib will be taken continuously until disease progression or unacceptable toxicity, in continuous treatment cycles of 28 days each, f…
Phase 2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Laser and compression may speed leg wound recovery
Disease control By invitation onlyThe purpose of this study is to determine the efficacy and safety of compression bandaging with fractional ablative carbon dioxide laser (FACL) compared to compression and standard dressings alone for healing of post-operative wounds of the leg. This is a randomized, SMART desig…
Sponsor: Northwestern University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Should all preterm babies get extra nutrients? new study tests routine fortification
Disease control CompletedThe aim of the project is to study the effects of fortification (using a Human Milk Donor Fortifier) of an exclusive preterm human milk diet on outcome of extremely preterm neonates, born at less or equal to 27 weeks.
Sponsor: Crouse Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Rheumatoid arthritis drug safety showdown: baricitinib vs. TNF inhibitors
Disease control CompletedThis post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous thromboembolic events (VTEs) when given to participants with rheumatoid arthritis (RA).
Phase 4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can your gut bacteria change how transplant drugs work?
Knowledge-focused OngoingThe purpose of this research is to study immunosuppression drugs, certain foods, and how they can change the microbiome (the natural microorganisms inside the body) of the individual taking the immunosuppressive medications. The study team wants to study how the microbiome affect…
Sponsor: The University of Texas Medical Branch, Galveston • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
AI could predict which heart ablations work best
Knowledge-focused Recruiting nowAtrial fibrillation is a serious public health issue that affects over 5 million Americans (Miyazaka, Circulation 2006) in whom it may cause skipped beats, dizziness, stroke and even death. Therapy for AF is currently suboptimal, in part because AF represents several disease stat…
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
New autism program helps parents help kids in Low-Income areas
Symptom relief CompletedThe ASD Screening and Parent ENgagement (ASPEN) program is a culturally adapted, parent-mediated intervention program. The ASPEN program is tailored to address social communication and behavioral difficulties that young children with developmental delays may experience in early c…
Sponsor: University of Texas at Austin • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Is waiting safe for AFib? new study tests delayed treatment
Disease control Recruiting nowThe AFFELECT -study compares two types of treatment modalities for acute atrial fibrillation or flutter for patients in whom rhythm control is desirable. The main purpose is to observe if these arrhythmias can be safely treated electively (within 5-9 days). All patients are recr…
Sponsor: Tampere University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New tool could help Brain-Injured patients breathe on their own sooner
Knowledge-focused Recruiting nowThe BIPER study is a stepped wedge cluster randomised clinical trial aiming to decrease extubation failure in critically-ill brain-injured patients with residual impaired consciousness using a simple clinical score.
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Spine radiation study aims to cut fracture risk
Symptom relief Recruiting nowSpine radiosurgery (SRS) utilizes advanced treatment planning with focused x-rays to deliver one to four high dose treatments to the spine to help relieve pain and/or neurologic symptoms. Spine SRS uses special equipment to position the participant and guide the focused beams tow…
Phase 2 • Sponsor: Case Comprehensive Cancer Center • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
Texts and talks in the ER boost child car safety
Disease control CompletedThis study involves an emergency department (ED)-based intervention utilizing Motivational Interviewing (MI) techniques and patient-centered eHealth materials (e.g., a tailored, mobile-friendly website and text messages) to promote the correct and consistent use of size-appropria…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Glue vs. heat vs. knife: which vein fix wins?
Disease control Stopped earlyGlobal, Post-Market, Prospective, Multi-Center, Randomized Controlled Trial of the VenaSeal™ Closure System vs. Surgical Stripping or Endothermal Ablation (ETA) for the Treatment of Early and Advanced Stage Superficial Venous Disease
Sponsor: Medtronic Endovascular • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC